It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
The effect of diabetes distress on glycemic control and its association with diabetes complications is still poorly understood. We aimed to study the clinical features of patients with high diabetes distress, focusing on changes in glycemic control and risk of diabetic complications. From the Korean National Diabetes Program data, we investigated 1862 individuals with type 2 diabetes mellitus (T2DM) who completed diabetic complication studies and the Korean version of the Problem Areas in Diabetes Survey (PAID-K). A total score of PAID-K ≥ 40 was considered indicative of high distress. Individuals with high distress (n = 589) had significantly higher levels of glycated hemoglobin than those without distress (7.4% vs. 7.1%, p < 0.001). This trend persisted throughout the 3-year follow-up period. Higher PAID-K scores were associated with younger age, female gender, longer duration of diabetes, and higher carbohydrate intake (all p < 0.05). There was a significant association between high distress and diabetic neuropathy (adjusted odds ratio, 1.63; p = 0.002), but no significant association was found with other complications, including retinopathy, albuminuria, and carotid artery plaque. In conclusion, high diabetes distress was associated with uncontrolled hyperglycemia and higher odds of having diabetic neuropathy.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details

1 Gangnam Severance Hospital, Yonsei University College of Medicine, Department of Internal Medicine, Seoul, Korea (GRID:grid.15444.30) (ISNI:0000 0004 0470 5454)
2 Inha University College of Medicine, Department of Endocrinology and Metabolism, Incheon, Korea (GRID:grid.202119.9) (ISNI:0000 0001 2364 8385)
3 Inha University College of Medicine, Department of Biomedical Sciences, Incheon, Korea (GRID:grid.202119.9) (ISNI:0000 0001 2364 8385)
4 Kyung Hee University School of Medicine, Department of Endocrinology and Metabolism, Seoul, Korea (GRID:grid.289247.2) (ISNI:0000 0001 2171 7818)
5 Korea University College of Medicine, Department of Internal Medicine, Seoul, Korea (GRID:grid.222754.4) (ISNI:0000 0001 0840 2678)
6 Ajou University School of Medicine, Department of Endocrinology and Metabolism, Suwon, Republic of Korea (GRID:grid.251916.8) (ISNI:0000 0004 0532 3933)
7 Inha University College of Medicine, Department of Endocrinology and Metabolism, Incheon, Korea (GRID:grid.202119.9) (ISNI:0000 0001 2364 8385); Inha University College of Medicine, Division of Endocrinology and Metabolism, Department of Internal Medicine, Incheon, Korea (GRID:grid.202119.9) (ISNI:0000 0001 2364 8385)